期刊文献+

上皮钙黏蛋白、雌激素受体α在子宫内膜癌变过程中的表达 被引量:6

Expression of E-cadherin and ERα during carcinogenesis of endometrium
下载PDF
导出
摘要 目的探讨上皮钙黏蛋白(E-cadherin)、雌激素受体α(ERα)在子宫内膜癌变过程中的表达及临床意义。方法应用免疫组化En Vision二步法检测28例不典型增生子宫内膜(AH)和55例子宫内膜样腺癌(EA)组织中E-cadherin、ERα蛋白表达,另设18例增殖期子宫内膜组织作对照组。结果 1对照组、AH组、EA组组织中Ecadherin蛋白异常表达率分别为5.6%(1/18)、35.7%和60%,ERα阳性率分别为72.2%、53.6%和45.5%,ERα表达强度逐渐减弱,组间比较差异显著(均P<0.05)。2EA组中,E-cadherin蛋白表达与肿瘤侵犯肌层相关(P<0.05),与患者月经状态、组织学分级、临床分期无关(P>0.05);ERα蛋白表达与肿瘤组织学分级相关(P<0.01),与患者月经状态、肌层浸润及临床分期无关(P>0.05)。E-cadherin与ERα的表达呈正相关(P<0.05)。结论 Ecadherin和ERα改变可能参与了子宫内膜癌变过程,在EA的发生、发展过程中二者可能具有某种协同作用。 Purpose To investigate the expression and clinical significance of E-cadherin and ERα protein during carcinogenesis of endometrium. Methods The expression of E-cadherin and ERα proteins in endometrial atypical hyperplasia tissues( n = 28)( AH group), endometrioid adenocarcinoma tissues( n = 55)( EA group) were examined by immunohistochemistry( En Vision method). Another 18 cases of proliferative endometrium tissues were used as a control group.Results In group of control,AH group and EA group,the abnormal expression rate of E-cadherin was 5. 6%,35. 7% and60. 0% respectively; The positive expression rates of ERα was 72. 2%,53. 6% and 45. 5% respectively and the signal intensity was decreasing. The differences among the three groups was atatistically significant( P〈0. 05). In EA group,the exprssion of E-cadherin was related to the muscle layer infiltration( P〈0. 05),but it was not associated with the menstrual status,histological grade and FIGO stage( P〉0. 05). The positive expression of ERα was related to the histological grade( P〈0. 01),but was not associated with menstrual status,muscle layer infiltration and FIGO stage( P〉0. 05). The expression of E-cadherin protein was positively related to that of ER( P〈0. 05). Conclusion The chang of E-cadherin and ERα protein may be involved in the pathogenesis of carcinogenesis of endometrium and may be associated with the pathogenesis and progression of endometrioid adenocarcinoma. Therefore,they may be has some synergistic effect in this process.
出处 《诊断病理学杂志》 CSCD 2015年第1期30-33,共4页 Chinese Journal of Diagnostic Pathology
基金 广西壮族自治区教育厅科研项目(编号:200911MS285及编号2013YB288)
关键词 子宫肿瘤 腺癌 上皮钙黏附蛋白 雌激素受体Α Uterine neoplasmas Adenocarcinoma E-cadherin ERα
  • 相关文献

参考文献19

  • 1Schmalhofer O, Brabletz S, Brabletz T. E-catenin, and ZEB1 in malignant progerssion of cancer [ J ]. Cancer Metast Rev, 2009, 28(1 -2) :151 - 166.
  • 2FattanehA,Devilee TP.乳腺及女性生殖器官肿瘤病理学与遗传学[M].程虹,等译.北京:人民卫生出版社,2006.276-279、285-288.
  • 3Thiery JP. Epithelial-mesenchymal transitions in tumor progression[J]. Nat Rev Caneer, 2002,2(6) :442 -454.
  • 4Faleiro RC, Lopes C. E-eadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix : an immunohistoehemical study E J 1. Pathobiology, 2004,71 (6) :329 -36.
  • 5Kogan EA, Niziaeva NV, Demura TA, et al. The morphological and immunohioehemieal features of loci of adenomyosis: in its concurrence with endometrial adenoearcinoma [ J ]. Arkh Patol, 2010,72(4) :7 - 12.
  • 6孔令娜,马晓欣,李艳霞.人垂体肿瘤转化基因在子宫内膜癌发生发展中作用的研究[J].中国医科大学学报,2009,38(8):611-614. 被引量:5
  • 7Samamthai N, Hall K, Yeh IT. Molecular profiling of endometrial malignancies[ J]. Obstet Gynecol Int, 2010,162363.
  • 8Mell LK, Meyer JJ, Tretiakova M, eta/. Prognostic significance of e-cadherin protein expression in pathological stage I-III endometrial cancer[J]. Clin Cancer Res, 2004,10(16) :5546-5553.
  • 9王玲,薛慧荣,王艳丽.上皮性钙粘蛋白和β-连环素与子宫内膜癌的关系[J].中国实验诊断学,2006,10(5):478-481. 被引量:8
  • 10黄筱竑,章彤华,平金良,袁慧琴.KAI1/CD82和E-cadherin在子宫内膜癌的表达[J].肿瘤学杂志,2009,15(9):855-858. 被引量:4

二级参考文献62

  • 1韩守威,何斌,唐茜萍,刘珊玲,彭芝兰,曹泽毅.女性生殖系统恶性肿瘤组织胞浆雌激素及孕激素受体的研究[J].中华妇产科杂志,1994,29(1):12-15. 被引量:27
  • 2Sinicrope FA, Dominguez A, Ramos-Morales F. hPTTG, a human homologue of rat pttg is overexpressed in hematopoietie neoplasms [J]. Oncogene, 1998,17( 17):2187-2193.
  • 3Solbach C,Roller M,Fellbaum C,et al. PTTG mRNA expression in primary breast cancer [ J ]. Breast, 2004, 13 ( 1 ) : 80-81.
  • 4McCabe CJ,Khaira JS,Boelaerl K,et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas:relationshios to clinical tumour behaviour [J]. Clin Endocrinol (Oxf), 2003,58(2) : 141-150.
  • 5McCabe CJ,Boelaert K,Tannahill LA,et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors [J]. J Clin Endocrinol Metab,2002,87 (9) :4238-4244.
  • 6[1]Nyholm HCJ,Nielsen AL,Lyndrup J,et al.Biochemical and immunohistochenical estrogen and progesterone receptors in adenomatous hyperplasic and endometrial carcinoma:Correlations with stage and other clinic pathologic features.Am Job stet Gynecol,1992,167:1334.
  • 7[2]KohlbergerPD,Kieback DG,Breitenecker F,etal.Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer:true color compute-assisted image analysis versus subjective scoring.Gynecology oncol,1997,64:404.
  • 8[3]Soper JT,Segreto EM,Novotmy DB,et al.Estrogen and progesterone receptor content of endometrial carcinomas:comparison of total tissue versus cancer component analysis.Gynecol Onclo,1990,36:363.
  • 9[5]Carcangiu ML,Chambers JT,Voynick IM,et al.Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma,part Ⅰ:clinical and histological correlations,Am J Clin Pathol,1990,94:247.
  • 10Meenakshi S, Zaino RJ, Filiaci V J, et al. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma : a gynecologic oncology group study [ J ] . Gynecol Oncol, 2007, 106 ( 2 ) : 325-333.

共引文献750

同被引文献71

  • 1黄筱竑,章彤华,平金良,袁慧琴.KAI1/CD82和E-cadherin在子宫内膜癌的表达[J].肿瘤学杂志,2009,15(9):855-858. 被引量:4
  • 2周芳芳,王娟,滕银成.子宫内膜癌组织中上皮型钙黏蛋白、神经型钙黏蛋白、雌激素受体、孕激素受体和P53的表达及意义[J].中华临床医师杂志(电子版),2011,5(19):5645-5649. 被引量:11
  • 3闫慧娴,谷伟军,杨国庆,黄薇,巴建明,王先令,杜锦,金楠,臧丽.桥本甲状腺炎与甲状腺乳头状癌关系的临床研究[J].中华内分泌代谢杂志,2014,30(4). 被引量:51
  • 4Onder T'F, Gujpta PB, Mani SA, Yang J, et al. Loss of E- cadherinn promotes metastasis via multiple downstream transcriptional pathways [ J ]. Cancer Research, 2008,68 ( 10 ) : 3645-3654.
  • 5Justin MD, Ayyappan K. Dishonorable discharge: The oncogenic roles of E-cadherinn fragments[ J] Cancer,2012,72(12) :2917- 2923.
  • 6DUrso PI, D'Urso OF, Storelli C, et al. Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma [ J ]. J Neurooncol, 2011,104 ( 1 ) : 113-118.
  • 7Paredes J, Figueiredo J, Albergaria A, et al. Epithelial E- and P- cadherins: Role and clinical significance in cancer[ J 1- RRA-Rev Cancer,2012,1826(2) :297-311.
  • 8Hartsock A, Nelson WJ. Adherens and tight junctions : Structure, function and connections to the actin cytoskeleton [ J ] BiochimBiophys Acta, 2008,1778 ( 3 ) : 660-669.
  • 9Shin Y, Kim IJ, Kang HC, et al. The E-eadherinn -347G/GA promoter polymorphism and its effect on transcriptional regulation [J]. Carcinogenesis,2004,25:895-899.
  • 10Nackley AG, Shabalina SA, Tehivileva IE, et al. Human catechol-O -methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science,2006, 314 : 1930-1933.

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部